Latest Insider Transactions at National Health Investors Inc (NHI)
This section provides a real-time view of insider transactions for National Health Investors Inc (NHI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NATIONAL HEALTH INVESTORS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NATIONAL HEALTH INVESTORS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2024
|
W Andrew Adams Director |
SELL
Other acquisition or disposition
|
Indirect |
12,635
-100.0%
|
-
|
|
Sep 25
2024
|
Kristin Sallee Gaines SVP/Chief Transaction Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
48,665
-45.65%
|
$4,087,860
$84.66 P/Share
|
|
Sep 25
2024
|
Kristin Sallee Gaines SVP/Chief Transaction Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
55,000
+17.55%
|
$3,795,000
$69.2 P/Share
|
|
Sep 18
2024
|
David L Travis SVP/Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,406
-39.33%
|
$884,510
$85.15 P/Share
|
|
Sep 18
2024
|
David L Travis SVP/Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+16.05%
|
$828,000
$69.2 P/Share
|
|
Sep 05
2024
|
D. Eric Mendelsohn CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
130,461
-59.5%
|
$10,697,802
$82.1 P/Share
|
|
Sep 05
2024
|
D. Eric Mendelsohn CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
164,999
+16.91%
|
$8,909,946
$54.57 P/Share
|
|
Sep 03
2024
|
Robert T Webb Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
52,353
-46.74%
|
$4,188,240
$80.04 P/Share
|
|
Sep 03
2024
|
Robert T Webb Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
70,000
+16.42%
|
$4,060,000
$58.77 P/Share
|
|
Sep 03
2024
|
John L Spaid CFO/EVP Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
49,637
-56.35%
|
$4,020,597
$81.43 P/Share
|
|
Sep 03
2024
|
John L Spaid CFO/EVP Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
62,167
+13.51%
|
$3,357,018
$54.57 P/Share
|
|
Aug 23
2024
|
Kevin Carlton Pascoe Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
101,230
-64.45%
|
$7,895,940
$78.63 P/Share
|
|
Aug 23
2024
|
Kevin Carlton Pascoe Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
117,167
+12.82%
|
$7,030,020
$60.2 P/Share
|
|
Aug 23
2024
|
John L Spaid CFO/EVP Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
65,463
-71.64%
|
$5,106,114
$78.63 P/Share
|
|
Aug 23
2024
|
John L Spaid CFO/EVP Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
73,333
+23.84%
|
$4,766,645
$65.25 P/Share
|
|
Aug 23
2024
|
James R Jobe Director |
SELL
Payment of exercise price or tax liability
|
Direct |
31,289
-52.17%
|
$2,440,542
$78.63 P/Share
|
|
Aug 23
2024
|
James R Jobe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+23.15%
|
$2,475,000
$55.3 P/Share
|
|
Aug 23
2024
|
David L Travis SVP/Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
22,839
-61.23%
|
$1,781,442
$78.63 P/Share
|
|
Aug 23
2024
|
David L Travis SVP/Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,300
+18.19%
|
$1,605,900
$53.58 P/Share
|
|
Aug 16
2024
|
Tracy M J Colden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+30.13%
|
$2,565,000
$57.31 P/Share
|
|
Aug 16
2024
|
Tracy M J Colden Director |
SELL
Payment of exercise price or tax liability
|
Direct |
35,143
-78.1%
|
$2,600,582
$74.29 P/Share
|
|
Jul 29
2024
|
Robert A Mccabe Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
32,711
-49.13%
|
$2,453,325
$75.21 P/Share
|
|
Jul 29
2024
|
Robert A Mccabe Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+21.0%
|
$2,475,000
$55.3 P/Share
|
|
May 31
2024
|
Robert A Mccabe Jr Director |
BUY
Open market or private purchase
|
Direct |
437
+1.98%
|
$28,405
$65.83 P/Share
|
|
May 06
2024
|
John L Spaid CFO/EVP Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
230
-1.26%
|
$14,720
$64.72 P/Share
|
|
Feb 27
2024
|
Charlotte A Swafford Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+8.32%
|
$580,000
$58.69 P/Share
|
|
Feb 23
2024
|
David L Travis SVP/Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+30.0%
|
-
|
|
Feb 23
2024
|
John L Spaid CFO/EVP Finance |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+14.1%
|
-
|
|
Feb 23
2024
|
Kevin Carlton Pascoe Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+6.99%
|
-
|
|
Feb 23
2024
|
Kristin Sallee Gaines SVP/Chief Transaction Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+5.49%
|
-
|
|
Feb 23
2024
|
D. Eric Mendelsohn CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+5.24%
|
-
|
|
Oct 01
2023
|
Robert G Adams Director |
SELL
Acquisition or disposition by will or laws
|
Indirect |
85,411
-100.0%
|
-
|
|
Aug 30
2023
|
James R Jobe Director |
BUY
Open market or private purchase
|
Direct |
1,000
+6.26%
|
$51,000
$51.4 P/Share
|
|
May 05
2023
|
Kevin Carlton Pascoe Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+9.78%
|
-
|
|
May 05
2023
|
John L Spaid CFO/EVP Finance |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+20.75%
|
-
|
|
May 05
2023
|
Kristin Sallee Gaines SVP/Chief Transaction Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+7.6%
|
-
|
|
May 05
2023
|
D. Eric Mendelsohn CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+8.89%
|
-
|
|
May 05
2023
|
David L Travis SVP/Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+50.0%
|
-
|
|
Dec 14
2022
|
Robert G Adams Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.55%
|
$56,000
$56.6 P/Share
|
|
Aug 26
2022
|
Kevin Carlton Pascoe Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,065
-32.81%
|
$1,076,355
$67.1 P/Share
|
|
Aug 26
2022
|
Kevin Carlton Pascoe Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,333
+27.24%
|
$971,649
$53.41 P/Share
|
|
Aug 15
2022
|
Robert G Adams Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+1.73%
|
$97,500
$65.93 P/Share
|
|
Dec 30
2021
|
Robert G Adams Director |
BUY
Open market or private purchase
|
Indirect |
2,000
+1.16%
|
$114,000
$57.25 P/Share
|
|
Dec 01
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
2,000
+2.35%
|
$102,000
$51.6 P/Share
|
|
Nov 29
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+2.44%
|
$52,000
$52.86 P/Share
|
|
Sep 30
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
2,000
+4.88%
|
$106,000
$53.86 P/Share
|
|
Sep 29
2021
|
D. Eric Mendelsohn CEO and President |
BUY
Open market or private purchase
|
Direct |
2,000
+1.07%
|
$108,000
$54.39 P/Share
|
|
Sep 17
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+3.9%
|
$85,500
$57.25 P/Share
|
|
Sep 16
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+4.05%
|
$85,500
$57.5 P/Share
|
|
Sep 14
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+4.23%
|
$87,000
$58.0 P/Share
|